Therapeutic bronchoscopy for malignant central airway obstruction: impact on quality of life and risk-benefit analysis

Curr Opin Pulm Med. 2022 Jul 1;28(4):288-293. doi: 10.1097/MCP.0000000000000883.

Abstract

Purpose of review: Malignant central airway obstruction (CAO) is a common complication in cancer and confers significant symptom burden and reduction in quality of life. Multiple bronchoscopic interventions exist for malignant CAO. In this review, we discuss the role of therapeutic bronchoscopy in the management of malignant CAO, emphasizing its impact on symptom control and quality of life while balancing the risks and benefits of intervention.

Recent findings: Significant practice variations exist among practitioners of therapeutic bronchoscopy, and limited data exist to guide real-time clinical decision-making. Recent analyses demonstrate that therapeutic bronchoscopy is effective for symptoms associated with malignant CAO with infrequent complications. These studies also show that many of the improvements in symptoms and quality of life are sustained after intervention and are associated with improved overall survival in patients with malignant CAO. Recent data have also shown that the improvement in symptoms associated with therapeutic bronchoscopy may enable more definitive cancer treatment, further improving patient outcomes.

Summary: Therapeutic bronchoscopy is safe and effective at improving patient-centered outcomes in malignant CAO. Research is ongoing to better understand its optimal role in this setting, refine decision-making regarding advanced bronchoscopic interventions, and further improve patient outcomes.

Publication types

  • Review

MeSH terms

  • Airway Obstruction* / etiology
  • Airway Obstruction* / therapy
  • Bronchoscopy
  • Humans
  • Neoplasms*
  • Quality of Life